IXC
Click for more information
1.41% 7.0¢ invex therapeutics ltd

Ann: Global Phase 3 Trial of Presendin to Launch in Q4 2021, page-154

  1. TheDerivative
    343 Posts.
    lightbulb Created with Sketch. 23
    clock Created with Sketch.
    18/11/21
    22:40
    Post #: 57687262
    I would have thought at least $2 or somewhere around $150M market cap for where we are in terms of trial status. There’s such a large disconnect from where we are and where we should be and this is what I’ve been struggling with for the last 18 months - regardless of the FDA approval.
    what is a miss? It’s the $100M question?!?


    IXC Price at posting: 62.0¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Hillcrest Partners with Ocean Batteries to Deploy ZVS Invert
right-arrow Created with Sketch.
TLX Telix dips as pharma giant abandons US IPO for NASDAQ listing – despite record run
right-arrow Created with Sketch.
NEWS Week 24 Wrap: US contagion sentiment not so contagious; iron ore remains pressured
right-arrow Created with Sketch.
CC9 Chariot Corporation marches forward with discovery-level drill program in Wyoming, USA
right-arrow Created with Sketch.
GT1 Green Technology hands the helm to Henry
right-arrow Created with Sketch.
AL8 "What is the focus of AL8 and how is management going to attract shareholders to the registry?"
right-arrow Created with Sketch.
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
7.0¢ 		Change
-0.001(1.41%) 		Mkt cap ! $5.261M
Open High Low Value Volume
7.1¢ 7.1¢ 7.0¢ $4.214K 59.36K

Buyers (Bids)

No. Vol. Price($)
1 198734 7.0¢
 

Sellers (Offers)

Price($) Vol. No.
7.6¢ 52542 1
View Market Depth
Last trade - 15.32pm 20/06/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.